Bioengineering Innovative Solutions for Cancer
Original price was: $151.73.$89.25Current price is: $89.25.
9780128138861, Academic Press, Ladame, Sylvain
Author: Ladame, Sylvain
Brand: Academic Press
Edition: 1
ISBN: 9780128138861
Release Date: 15-11-2019
Package Dimensions: 9.3 x 7.5 x 0.9 inches
Languages: English
Binding: paperback
Number Of Pages: 393
Details: Bioengineering Innovative Solutions for Cancer bridges the gap between bioengineering and cancer biology. It focuses on a ‘bottom up’ understanding of the links between molecules, cells, tissues, organs, organisms, and health and functions―all within a bioengineering context. Chapters cover the main methods, technologies and devices that could help diagnose cancer sooner (e.g., ultrasensitive imaging and sensing technologies) and helpful treatments (e.g., new, more targeted therapies). The book takes an interdisciplinary approach that is ideal for those who need the latest information on design techniques and devices that help treat cancer using new, more targeted therapies.
By covering the many different ways engineers can deliver innovative solutions to tackle cancer, this book is a valuable read for researchers who have an ambition to make an impact on people’s life in either an academic or industrial setting. Connects bioengineering and cancer biology, providing information on sensors, imaging, therapies and in-vitro models Presents the most comprehensive coverage in the field of cancer engineering to date Provides an academic introduction to (molecular) bioengineering for students, regardless of scientific background (math’s, physics, chemistry, biology) Highlights the unmet medical needs for bioengineers and the main technological breakthroughs to cancer biologists
User Reviews
Be the first to review “Bioengineering Innovative Solutions for Cancer”
Vendor Information
- Store Name: Adobooks Marketplace
- Vendor: Adobooks Marketplace
- No ratings found yet!
Product Enquiry
Original price was: $151.73.$89.25Current price is: $89.25.


There are no reviews yet.